Cannara Biotech Inc. announced the appointment of Dr. Sara May, PhD. to the company's Board of Directors, effective immediately. Dr. May is recognized as an expert in the medical cannabis sector and will bring additional skill sets and help strengthen the company's Board. Dr. Sara May has held numerous leadership positions within the medical cannabis industry overseeing project operations, implementing quality control/quality assurance measures, as well as standard operating procedures. Dr. May is the current president of FV Pharma and replaces outgoing former president of FV Pharma, Thomas Fairfull, on Cannara's Board of Directors.